×
About 124,298 results

ALLMedicine™ Tuberculosis Center

Research & Reviews  60,353 results

Sarcoidosis presenting with glazy mucoid sputum and dyspnea: a case report.
https://doi.org/10.1186/s13256-021-02809-2 10.1056/NEJMra071714 10.3389/fmed.2020.594275 10.1001/jama.2011.10 10.1055/s-0030-1262218 10.1164/rccm.200603-402OC 10.2165/00063030-200317060-00005 10.1016/j.rmed.2007.08.014 10.1016/j.semarthrit.2018.10.005 10.1513/AnnalsATS.201511-760OC
Journal of Medical Case Reports; Al-Kailany W, Timens W et. al.

May 11th, 2021 - Patients with pulmonary sarcoidosis commonly present with a dry cough; a productive cough suggests a complicating airway infection or an alternative diagnosis such as tuberculosis or bronchiectasis. A 36-year-old European (Frisian) woman recently ...

Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacter...
https://doi.org/10.1128/AAC.02617-20
Antimicrobial Agents and Chemotherapy; Mok S, Roycroft E et. al.

May 11th, 2021 - Pyrazinamide (PZA) is one of the first-line agents used for the treatment of tuberculosis. However, current phenotypic PZA susceptibility testing in the BACTEC MGIT 960 system is unreliable and false resistance is well documented. Rapid identifica...

Biological and biochemical evaluation of isatin-isoniazid hybrids as bactericidal candi...
https://doi.org/10.1128/AAC.00011-21
Antimicrobial Agents and Chemotherapy; Johansen MD, Shalini et. al.

May 11th, 2021 - Tuberculosis remains a leading cause of mortality among infectious diseases worldwide, prompting the need to discover new drugs to fight this disease. We report herein, the design, synthesis and anti-mycobacterial activity of isatin-mono/bis-isoni...

Is the BCG vaccine a useful tool against COVID-19?
https://doi.org/10.1016/j.clindermatol.2020.12.018
Clinics in Dermatology; Zhelezova G, Mateeva V et. al.

May 11th, 2021 - The Bacillus Calmette-Guérin (BCG) vaccine has been used since 1921 initially for protection against tuberculosis. BCG acts through stimulation of cell-mediated adaptive immunity with activation of the Th1 cells and production of interferon gamma....

see more →

Guidelines  127 results

Tuberculosis — United States, 2020
https://www.cdc.gov/mmwr/volumes/70/wr/mm7012a1.htm
MMWR Morb Mortal Wkly; Deutsch-Feldman M, Pratt RH et. al.

Mar 25th, 2021 - Tuberculosis (TB) disease incidence has decreased steadily since 1993 (1), a result of decades of work by local TB programs to detect, treat, and prevent TB disease and transmission. During 2020, a total of 7,163 TB cases were provisionally report...

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tub...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045826
Emerging Infectious Diseases; Campbell JR, Falzon D et. al.

Jan 10th, 2020 - International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which...

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
https://www.atsjournals.org/doi/full/10.1164/rccm.201909-1874ST
American Journal of Respiratory and Critical Care Medicine; Payam Nahid et al

Nov 20th, 2019 - The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis ...

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857485
American Journal of Respiratory and Critical Care Medicine; Nahid P, Mase SR et. al.

Nov 15th, 2019 - Background: The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant t...

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
https://www.nejm.org/doi/full/10.1056/NEJMoa1909953
The New England Journal of Medicine; Tait,D.,et al

Oct 28th, 2019 - BACKGROUND Results of an earlier analysis of a trial of the M72/AS01E candidate vaccine against Mycobacterium tuberculosis showed that in infected adults, the vaccine provided 54.0% protection against active pulmonary tuberculosis disease, without...

see more →

Drugs  249 results see all →

Clinicaltrials.gov  61,919 results

Sarcoidosis presenting with glazy mucoid sputum and dyspnea: a case report.
https://doi.org/10.1186/s13256-021-02809-2 10.1056/NEJMra071714 10.3389/fmed.2020.594275 10.1001/jama.2011.10 10.1055/s-0030-1262218 10.1164/rccm.200603-402OC 10.2165/00063030-200317060-00005 10.1016/j.rmed.2007.08.014 10.1016/j.semarthrit.2018.10.005 10.1513/AnnalsATS.201511-760OC
Journal of Medical Case Reports; Al-Kailany W, Timens W et. al.

May 11th, 2021 - Patients with pulmonary sarcoidosis commonly present with a dry cough; a productive cough suggests a complicating airway infection or an alternative diagnosis such as tuberculosis or bronchiectasis. A 36-year-old European (Frisian) woman recently ...

Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacter...
https://doi.org/10.1128/AAC.02617-20
Antimicrobial Agents and Chemotherapy; Mok S, Roycroft E et. al.

May 11th, 2021 - Pyrazinamide (PZA) is one of the first-line agents used for the treatment of tuberculosis. However, current phenotypic PZA susceptibility testing in the BACTEC MGIT 960 system is unreliable and false resistance is well documented. Rapid identifica...

Biological and biochemical evaluation of isatin-isoniazid hybrids as bactericidal candi...
https://doi.org/10.1128/AAC.00011-21
Antimicrobial Agents and Chemotherapy; Johansen MD, Shalini et. al.

May 11th, 2021 - Tuberculosis remains a leading cause of mortality among infectious diseases worldwide, prompting the need to discover new drugs to fight this disease. We report herein, the design, synthesis and anti-mycobacterial activity of isatin-mono/bis-isoni...

Is the BCG vaccine a useful tool against COVID-19?
https://doi.org/10.1016/j.clindermatol.2020.12.018
Clinics in Dermatology; Zhelezova G, Mateeva V et. al.

May 11th, 2021 - The Bacillus Calmette-Guérin (BCG) vaccine has been used since 1921 initially for protection against tuberculosis. BCG acts through stimulation of cell-mediated adaptive immunity with activation of the Th1 cells and production of interferon gamma....

see more →

News  1,627 results

TB Regimen Cuts Treatment Time by a Third
https://www.medscape.com/viewarticle/950763

May 6th, 2021 - A new drug combination containing rifapentine and moxifloxacin has finally broken the 6-month treatment barrier for drug-susceptible pulmonary tuberculosis, requiring only 4 months to produce a disease-free state at 1 year in most patients. The fi...

Shorter Tuberculosis Regimen With Moxifloxacin Not Inferior to 6-Month Treatment
https://www.medscape.com/viewarticle/950608

May 5th, 2021 - NEW YORK (Reuters Health) - A new rifapentine-based regimen with moxifloxacin can shorten the treatment time for drug-susceptible pulmonary tuberculosis, the authors behind a new phase-3 test report. "This is the first time in 40 years wherein tre...

South Africa Launches TB Mobile Clinics Amid COVID-19 Disruption
https://www.medscape.com/viewarticle/948203

Mar 28th, 2021 - CAPE TOWN (Reuters) - Parked on the roadside next to a graveyard in Cape Town's Gugulethu township, a tuberculosis hotspot, a team of health workers set up a makeshift TB screening room next to their van. Gladys Rara, 45, provides a sputum sample ...

Tuberculosis — United States, 2020
https://www.cdc.gov/mmwr/volumes/70/wr/mm7012a1.htm
MMWR Morb Mortal Wkly; Deutsch-Feldman M, Pratt RH et. al.

Mar 25th, 2021 - Tuberculosis (TB) disease incidence has decreased steadily since 1993 (1), a result of decades of work by local TB programs to detect, treat, and prevent TB disease and transmission. During 2020, a total of 7,163 TB cases were provisionally report...

Pediatric TB – More Work Needed, Especially With HIV Coinfection
https://www.medscape.com/viewarticle/947195

Mar 9th, 2021 - Despite recent advances in the diagnosis, treatment, and prevention of pediatric tuberculosis in children living with HIV (CLHIV) and HIV-exposed uninfected children (HEU), several unmet needs remain, including studies evaluating the feasibility o...

see more →

Patient Education  23 results see all →